In a new study, researchers from @MGHCancerCenter @broadinstitute and colleagues investigated why breast #cancer therapy tamoxifen may lead to higher risk of uterine cancer.
Read more: https://t.co/Jdd6mt19c0 https://t.co/x4WaWEBOzI @getz_lab
On #WorldLungCancerDay, we focus on BSF-supported U.S.–Israel research tackling one of cancer’s toughest challenges: persister cells.
Dr. Yaara Oren @TelAvivUni & Dr. Gad Getz @broadinstitute are uncovering how these elusive cells survive therapy - and how we might stop them.
1/ 🧵Check out our new study in @NatureGenet, which examines how precancerous conditions (MGUS/SMM) evolve into Multiple Myeloma, and offers new computational methods to predict progression risk and model cancer evolution.
https://t.co/IHnN87QKTk
In a new study, researchers from @MGHCancerCenter and colleagues' 'cell line atlas' provides a crucial resource for developing therapies for biliary tract cancer. The study was published in @CD_AACR.
Read more: https://t.co/jrK1pkGGfI @getz_lab @DrFranVazquez
https://t.co/RbppThCbqB
Now online in @CD_AACR: Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets - by @Vindhya_Vijay, Negin Karisani,@getz_lab, Nabeel Bardeesy, and colleagues https://t.co/WuDOQUg14x @MGHCancerCenter @broadinstitute
Excited to share our comprehensive cell line atlas for biliary tract cancer (BTC) in collab with Dr. Nabeel Bardeesy @MGHCancerCenter & @DrFranVazquez, and led by @Vindhya_Vijay & Negin Karisani! https://t.co/ifDaogY4zE @CancerDepMap@CD_AACR
Also see: https://t.co/6zvHg38On9
Our paper on establishing targeted therapy for MM with 1q+ is online ahead of print in @BloodJournal! w/ Liz Lightbody, Mairead Reidy, @IrenemGhobrial@gaddyg & Salomon Manier! https://t.co/TyduhtJ9tW
Let's walk through what we found in our new study using single-cell RNA-seq on tumor and immune cells from pts w/ asymptomatic Waldenstrom's Macroglobulinemia - out now in @NatureComms! W/ @Yoshi_konnykid@IrenemGhobrial@gaddyg#wmsm#mmsm https://t.co/1Q1yh2rL1c 1/
Check out our new study using single-cell RNA-seq to characterize immune dysregulation and identify molecular subtypes in patients with asymptomatic Waldenstrom’s Macroglobulinemia! #wmsm
W/ @Yoshi_konnykid , @IrenemGhobrial, @getz_lab@WMIWMF
https://t.co/1Q1yh2siQK
Our new perspective article describing the human and non-human primate developmental GTEx projects is now out in @Nature! We outline the scope, vision, opportunities and challenges of these projects here:
https://t.co/8T9otAvQTx
With @rheinbay_lab and additional Broad collaborators, we are excited to enter into this partnership with @Inocras to analyze whole genomes for the benefit of cancer research and cancer patients 🧬! @GenomeDoctor@BroadInstitute @MGHCancerCenter
We are excited that we (@inocras) start a collaboration on large-scale cancer whole-genome analyses with Gad Getz (@getz_lab) and colleagues at the Broad Institute!
Six leading scientists and longtime members of the Broad community have been named as new core institute members at Broad: @getz_lab, @AnnaGreka, Nir Hacohen, @macosko, @bmneale, and @pardissabeti Congratulations to all! https://t.co/bYnMpmTrEL
We thank Ofer Shoshani @ShoshaniOfer , Uri Ben-David @BenDavidLab and Yossi Yarden, Cancer Genome Structure & Dynamics meeting (https://t.co/LuD9varfj0). It was a great meeting and it was nice to meet Gaddy Getz @gaddyg as well.
Excited to present at #FOGBoston tomorrow on making @UltimaGenomics turnkey compatible with all existing downstream tools, with a real-world example leveraging methodology developed here in the @getz_lab to infer cancer phylogenies at resolutions not possible without #WGS.
“As someone who’s been rowing for a pretty long time, I think it’s really important to have a balance between two things that you find value in.” Learn how computational biologist @lizd0m juggles research and life as an elite rower in a #WhyIScience Q&A: https://t.co/YCCyPiwmXQ
Our own @GeffenYifat is featured this month as the #NCIProteomics Spotlight on Early-Career Investigators Series for her wonderful work in the Clinical Proteomic Tumor Analysis Consortium #CPTAC 👏🎉! Check out her interview in the link below. @BroadInstitute@theNCI